XL TechGroup is a unique, market driven value creation company
We use a proven, systematic methodology to invent, build, fund, manage and grow to liquidity our own succession of market-changing companies in the BioTech, EcoTech and MedTech sectors. This methodology has delivered a success rate of 70% since 1993.
XL TechGroup companies always start with the identification of significant unmet market needs that are brought to us by our Corporate Discovery partners, who are usually Fortune 100 global multinationals. Each unmet need is then matched with a potential technology solution from one of our world-leading Technology Partners, before being subjected to a set of 13 rigorous filters to screen and assess their potential.
The core members of our management team, who have successfully practiced this methodology since 1993, include highly experienced, successful professionals with backgrounds in science, business, operations and strategy.
Disclaimer for US Site Visitors
This web site contains investor-related information that is directed only to non-US persons. The investor-related and other information provided on this web site is for use only by non-U.S persons, and is not an offer to buy or sell, or a solicitation of an offer to buy or sell, any XL TechGroup securities. Moreover, we may not offer or sell XL TechGroup securities in the U.S. absent registration or an exemption from registration. If you are a U.S. person, or a person acquiring XL TechGroup ordinary shares for the account or benefit of any U.S. person, you agree and acknowledge that XL TechGroup's ordinary shares have not been registered under the U.S. Securities Act of 1933, as amended, and any offer or sale of XL TechGroup securities by XL TechGroup or its affiliates may be made solely pursuant to an exemption from the U.S. Securities Act of 1933, as amended.